Fluoxetine - Eli Lilly
Alternative Names: LY 110140; Prozac; Prozac Weekly; Reneuron; SarafemLatest Information Update: 05 Nov 2023
At a glance
- Originator Eli Lilly and Company
- Class Antidepressants; Anxiolytics; Behavioural disorder therapies; Eye disorder therapies; Propylamines; Small molecules
- Mechanism of Action Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Bulimia nervosa; Major depressive disorder; Obsessive-compulsive disorders; Panic disorder; Premenstrual dysphoric disorder
- Discontinued Dysthymic disorder; Post-traumatic stress disorders
Most Recent Events
- 08 May 2020 Allergan has been acquired and merged into AbbVie
- 01 Mar 2015 Eli Lilly completes a phase III extension trial in Major depressive disorder in Japan (NCT01808651)
- 01 Jul 2014 Eli Lilly completes a phase III trial in Major depressive disorder in Japan (NCT01808612)